Covered recipient · General Payments record
GUIRAGOS SARKIS MINASSIAN
Allopathic & Osteopathic Physicians Pediatrics
General Payments · PY2018–2024
$899.31
- Reported across 21 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $292.78 | 10 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $116.99 | 2 |
| Merck Sharp & Dohme Corporation | $54.61 | 2 |
| SANOFI-AVENTIS U.S. LLC | $43.07 | 2 |
| Cranial Technologies, Inc | $36.67 | 2 |
| GlaxoSmithKline, LLC. | $22.10 | 1 |
| ALK-Abello, Inc | $19.34 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (10)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ALK-Abello, Inc | $19.34 | 01/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1099893295 | CMS |
| Cranial Technologies, Inc | $16.07 | 07/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1082236402 | CMS |
| Cranial Technologies, Inc | $20.60 | 10/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1082236404 | CMS |
| GlaxoSmithKline, LLC. | $22.10 | 03/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115925492 | CMS |
| Merck Sharp & Dohme LLC | $22.17 | 04/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141742877 | CMS |
| Merck Sharp & Dohme LLC | $32.44 | 11/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141985297 | CMS |
| Novo Nordisk Inc | $56.73 | 08/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096916838 | CMS |
| Novo Nordisk Inc | $60.26 | 10/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097226436 | CMS |
| SANOFI-AVENTIS U.S. LLC | $22.58 | 10/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139859984 | CMS |
| SANOFI-AVENTIS U.S. LLC | $20.49 | 12/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139860004 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.